Portfolio Company · Operating Co.
Company Snapshot
Dorian Therapeutics is a portfolio company held by Blumberg Capital. Profile compiled from public sources; submit updates to extend the public record.
Ownership Context
Dorian Therapeutics is a current portfolio company of Blumberg Capital. Public coverage of this company is grouped under its parent firm's profile.
Sources
https://blumbergcapital.com/companiesThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Dorian Therapeutics and does not provide investment advice.
Other portfolio companies of Blumberg Capital
See the full Blumberg Capital portfolio.